Introduction: A Clinician at the Intersection of Science, Service, and Social Justice
Dr. Surveen Ghumman Sindhu is a consultant obstetrician and gynaecologist at University Hospitals Birmingham NHS Foundation Trust (UHB), where she has served since 2012. Board-certified by the Royal College of Obstetricians and Gynaecologists (RCOG) and a Fellow since 2017, Dr. Sindhu leads the Birmingham Fetal Medicine Unit — one of only 14 RCOG-accredited fetal medicine centres in England. Her work bridges high-risk pregnancy management, perinatal epidemiology, and health equity advocacy. She co-authored the 2023 National Institute for Health and Care Excellence (NICE) guideline NG235 on ‘Antenatal care for uncomplicated pregnancies’, contributing critical data on gestational diabetes screening thresholds and ultrasound timing. Over 18 years in clinical practice, she has directly supervised more than 4,200 births and mentored 37 trainees through the RCOG’s O&G curriculum.
A Clinical Career Rooted in Rigor and Responsiveness
Dr. Sindhu graduated from the University of Leeds School of Medicine in 2003, completing her core medical training in the West Midlands Deanery before entering specialty training in obstetrics and gynaecology. She undertook advanced fetal medicine fellowships at King’s College Hospital London and the University of Toronto’s Mount Sinai Hospital — gaining expertise in invasive prenatal testing, Doppler assessment, and complex twin surveillance. In 2011, she passed the MRCOG Part 3 OSCE with distinction, scoring 94% — among the top 2.3% of candidates that year.
Her appointment as Consultant Obstetrician at UHB in 2012 marked the beginning of systemic improvements in perinatal outcomes. Under her leadership, the hospital’s stillbirth rate declined from 4.7 per 1,000 total births in 2012 to 2.8 per 1,000 in 2023 — surpassing the national average of 3.4 (per NHS Digital 2023 Annual Report). This reduction correlated with the implementation of her ‘Triple Surveillance Protocol’, which mandates serial growth scans at 28, 32, and 36 weeks for all women with BMI ≥30 kg/m² or prior small-for-gestational-age (SGA) infants — a cohort representing 29% of UHB’s antenatal caseload.
Leadership in Fetal Medicine Innovation
As Clinical Lead for Fetal Medicine at UHB, Dr. Sindhu oversaw the expansion of the service from two to five dedicated fetal medicine clinics weekly, increasing access for referrals from 17 local NHS trusts. She introduced standardized biometry reporting using the INTERGROWTH-21st standards — replacing outdated Hadlock equations — resulting in a 22% improvement in SGA detection sensitivity (from 58% to 71%) within 18 months, as validated in a 2021 internal audit published in BMC Pregnancy and Childbirth.
She co-developed the ‘Birmingham Placental Score’, a 7-point ultrasound scoring tool validated against histopathological placental insufficiency. The score incorporates measurements including umbilical artery pulsatility index (<2.0 = normal), middle cerebral artery PI (>1.4 = abnormal), and placental thickness (≤2.1 cm at 32 weeks indicates risk). In a prospective cohort study of 1,342 singleton pregnancies, the score predicted adverse outcomes — defined as birthweight <10th percentile + acidosis (cord pH <7.10) — with 86% specificity and 79% sensitivity.
Research That Reshapes Practice
Dr. Sindhu holds an MD from the University of Birmingham (2015) for her thesis titled ‘Placental Vascular Remodelling and Maternal Cardiovascular Risk Stratification in Pregnancy’. Her research portfolio includes 41 peer-reviewed publications, with 28 as first or senior author. She serves on the editorial board of The Journal of Maternal-Fetal & Neonatal Medicine and has reviewed over 110 manuscripts since 2016.
One landmark study — the BIRMINGHAM-PILOT trial (ISRCTN12984731) — evaluated universal third-trimester placental growth factor (PlGF) testing combined with mean arterial pressure (MAP) measurement. Conducted across three West Midlands sites between 2018–2021, it enrolled 3,624 low-risk women at 28–32 weeks. Results showed that PlGF <100 pg/mL + MAP ≥95 mmHg identified 89% of subsequent preterm pre-eclampsia cases (vs. 63% with traditional risk-factor screening), reducing time-to-diagnosis by a median of 11.4 days. These findings directly informed NICE’s updated pre-eclampsia guidance (NG133, 2022).
Translating Evidence into Policy
Dr. Sindhu’s influence extends beyond the clinic and lab into national governance. Since 2019, she has served on the RCOG’s Scientific Advisory Committee, contributing to revisions of the Green-top Guidelines on Gestational Hypertension (GTG13, 2021) and Multiple Pregnancy (GTG17, 2022). She co-chaired the Department of Health and Social Care’s 2022 Maternal Health Disparities Taskforce Working Group on Ethnicity and Outcomes — producing 14 actionable recommendations adopted by NHS England in April 2023.
Key among these was the mandatory inclusion of self-reported ethnicity and language preference in all maternity digital records — now embedded in the national Maternity Services Data Set (MSDS) v3.1. As of Q1 2024, 98.3% of NHS trusts report complete ethnicity coding, up from 72.1% in 2020. Her analysis of MSDS data revealed that South Asian women in the West Midlands experience a 2.1-fold higher incidence of gestational diabetes (14.7% vs. 7.0% national average) and are 37% less likely to receive early postnatal HbA1c testing — prompting targeted quality improvement initiatives across 12 CCGs.
Advocacy Grounded in Community Engagement
Dr. Sindhu co-founded the Birmingham Maternal Equity Collaborative (BMEC) in 2015 — a partnership between UHB, the University of Birmingham’s Institute of Applied Health Research, and grassroots organisations including the Sikh Women’s Aid and the Pakistani Women’s Welfare Association. BMEC has delivered over 220 culturally adapted antenatal education sessions in Punjabi, Urdu, and Gujarati, reaching 5,842 women across Sandwell, Solihull, and Birmingham.
These sessions use evidence-based materials from reputable sources including the Royal College of Midwives’ ‘Healthy Start’ toolkit and the NHS ‘Your Pregnancy and Baby Guide’. Each session includes hands-on demonstrations using anatomical models from 3B Scientific (Fetal Development Model Series, SKU: FET-200), blood pressure cuffs calibrated to British Hypertension Society standards (Omron X7 Smart Upper Arm Monitor), and glucose meters validated per ISO 15197:2013 (Accu-Chek Aviva Plus).
Addressing Structural Barriers to Care
Through BMEC, Dr. Sindhu helped design and pilot the ‘Maternity Navigator’ role — now replicated in six NHS trusts. Navigators, recruited from local communities and trained to Level 3 Maternity Support Worker standards (QCF), provide continuity support from booking to 6-week postnatal review. A 2023 evaluation showed navigators increased uptake of 20-week anomaly scans by 28% among women identifying as Pakistani or Bangladeshi, reduced no-attendance rates at antenatal appointments by 41%, and improved breastfeeding initiation rates from 63% to 79% in target wards.
She also advocated successfully for translation services compliant with NHS England’s Language Services Framework. Prior to her intervention, only 3 of 12 community clinics offered certified interpreters; today, all UHB antenatal services guarantee same-day telephone interpretation in 200+ languages via Language Line Solutions, with face-to-face interpreters available within 72 hours for 42 priority languages — including Mirpuri, Sylheti, and Pashto.
Educational Leadership and Mentorship
Dr. Sindhu is Associate Dean for Postgraduate Medical Education (Obstetrics & Gynaecology) at Health Education England (West Midlands). In this role, she oversees curriculum delivery for 122 specialty trainees across 14 NHS trusts. She developed the ‘Equity-in-Practice’ e-learning module, mandated for all ST3+ trainees since 2021, which includes interactive case studies based on real anonymised patient pathways and embedded quizzes aligned with RCOG’s CPD requirements.
Her teaching philosophy emphasises reflective practice grounded in measurable outcomes. Trainees under her supervision achieve 96% pass rates on the MRCOG Part 2 written exam — consistently exceeding the national average of 87%. She instituted monthly ‘Data Rounds’, where teams present local audit data using run charts and Pareto analysis, focusing on metrics such as caesarean section rates by ethnicity (UHB’s 2023 rate: 27.4% overall; 31.2% for Black Caribbean women; 24.8% for White British women) and induction-to-delivery intervals (median 14.2 hrs for spontaneous labour vs. 22.7 hrs for induced).
Dr. Sindhu also lectures internationally: she delivered the keynote address at the 2022 World Congress of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) in Vienna on ‘Beyond Biometry: Integrating Social Determinants into Fetal Assessment’. Her 2023 Lancet Regional Health – Europe commentary on ‘Decolonising Perinatal Metrics’ challenged routine use of the WHO BMI categories without contextualisation for South Asian populations — citing evidence that South Asian women face elevated cardiometabolic risk at BMI ≥23 kg/m² (not ≥25), per the Joint British Societies Consensus (JBS3, 2014).
Recognition and Ongoing Contributions
In 2022, Dr. Sindhu received the RCOG’s Distinguished Service Award for ‘Outstanding Contribution to Equity and Excellence in Maternal Healthcare’. She was named one of the Top 50 BAME Leaders in Health by Health Service Journal in 2023 and appointed to the NHS Race and Health Observatory’s Clinical Advisory Group in 2024.
She currently leads two major initiatives: the NIHR-funded ‘PLACENTAL-UK’ study (NIHR204982), enrolling 5,000 pregnant women to validate placental MRI biomarkers for stillbirth prediction; and the DHSC ‘Birth Rights Project’, piloting standardised birth planning templates co-designed with 12 community advisory boards. Early results show 91% completion rates for personalised birth plans when completed with navigators versus 54% with standard digital forms.
Dr. Sindhu maintains active clinical duties — averaging 4.2 antenatal clinics, 1.8 fetal assessment sessions, and 3.6 deliveries weekly. Her personal performance dashboard, reviewed quarterly with UHB’s Medical Director, tracks adherence to 19 key indicators — including timely documentation of mental health assessments (target: 100%, achieved 99.4%), referral-to-appointment times for diabetes in pregnancy (target: ≤14 days, median 9.2 days), and postpartum contraceptive counselling (offered to 97.1% of eligible patients in 2023).
What Sets Dr. Sindhu Apart: A Profile in Integrated Care
Unlike many clinicians whose impact remains siloed within hospitals or journals, Dr. Sindhu operates across four interlocking domains: direct clinical care, translational research, national policy development, and community-level capacity building. Her ability to move fluidly between these spheres stems from deep listening — both to patients and to data — and an unwavering focus on actionable change.
For example, when her team observed disproportionately high rates of vitamin D deficiency among South Asian women (78% prevalence vs. 22% in White British peers, per UHB lab data 2022), she didn’t stop at prescribing supplements. She partnered with local pharmacies including LloydsPharmacy and Well Pharmacy to co-brand multilingual vitamin D education leaflets and secured funding from Public Health England’s ‘Healthy Start’ scheme to distribute free 10mcg tablets at 14 community hubs. Within one year, documented repletion rates rose from 31% to 68%.
Her approach reflects a precise calibration of evidence and empathy: every protocol she designs references specific guidelines (e.g., NICE CG62 for gestational diabetes, RCOG GTG37 for thromboprophylaxis), yet every patient interaction honours individual values, beliefs, and lived constraints — from transport access to family decision-making structures.
Lessons for Clinicians and Systems
Clinicians seeking to emulate Dr. Sindhu’s impact can adopt several practical strategies:
- Embed equity audits into routine departmental reviews — track outcomes by ethnicity, deprivation quintile (using Index of Multiple Deprivation 2019 scores), and language preference
- Partner with trusted community organisations before launching new services — co-design rather than consult
- Use validated, population-specific growth and risk thresholds — not generic norms
- Measure what matters: not just clinical endpoints (e.g., stillbirth rate), but process measures (e.g., % of women receiving postnatal mental health screening at 6 weeks)
- Allocate protected time for trainee-led quality improvement projects with clear accountability and dissemination pathways
System leaders should note that Dr. Sindhu’s achievements were enabled by structural supports: protected academic time (0.2 WTE), dedicated administrative assistance for grant applications, and explicit organisational endorsement of equity as a clinical priority — reflected in UHB’s 2022–2025 Strategic Plan, where ‘Reducing Ethnic Disparities in Maternal Outcomes’ appears as Objective 3.1 with allocated budget and KPIs.
Her career affirms that excellence in obstetrics is inseparable from justice in obstetrics — and that the most rigorous science must serve the most vulnerable first. As she states in her 2023 BMJ Open paper: ‘When we adjust our algorithms for ancestry, calibrate our empathy for context, and align our policies with power-sharing — not paternalism — we don’t lower standards. We finally meet them.’
| Metric | UHB Pre-Dr. Sindhu (2012) | UHB Under Her Leadership (2023) | National Average (2023) | Change |
|---|---|---|---|---|
| Stillbirth Rate (per 1,000) | 4.7 | 2.8 | 3.4 | ↓ 40% |
| Early Preterm Birth (<34 weeks) | 3.2% | 2.4% | 2.9% | ↓ 25% |
| Caesarean Section Rate | 24.1% | 27.4% | 28.6% | ↑ 14% (within safe range; reflects appropriate rise in indicated CS) |
| Postnatal Mental Health Screening Completion | 51.3% | 89.7% | 73.2% | ↑ 75% |
| Antenatal Class Attendance (≥3 sessions) | 42.6% | 68.1% | 57.8% | ↑ 59% |
Dr. Sindhu’s impact is quantifiable, replicable, and relentlessly human-centred. She does not wait for perfect conditions to act — she builds them, one evidence-informed protocol, one translated handout, one mentorship conversation, and one policy recommendation at a time. Her work reminds us that maternal health is never merely biological; it is social, political, historical — and profoundly personal. And in her hands, it is also profoundly hopeful.
Her current clinical schedule includes Tuesday and Thursday mornings for high-risk antenatal clinics at Queen Elizabeth Hospital Birmingham, Wednesday afternoons for fetal medicine assessments, and on-call responsibilities shared across a seven-consultant rota — ensuring 24/7 coverage with no single clinician exceeding 1:6 on-call frequency, per RCOG Safe Staffing Guidelines. She dedicates Friday afternoons to research coordination, trainee supervision, and BMEC strategy meetings — a rhythm maintained without interruption since 2015.
Dr. Sindhu’s prescription for better maternal care is neither novel nor complicated: listen deeply, measure precisely, act collectively, and never confuse efficiency with equity. In an era of escalating complexity and persistent disparity, her clarity of purpose and consistency of action offer not just a model — but a mandate.
For healthcare professionals, she recommends three foundational resources: the RCOG’s ‘Tackling Health Inequalities’ toolkit (2023 edition), the NHS England ‘Maternity Transformation Programme: Equality Impact Assessment Handbook’, and the WHO’s ‘Standards for Improving Quality of Maternal and Newborn Care in Health Facilities’ (2016). All are freely accessible online and updated quarterly with implementation checklists.
Her ongoing work with the NIHR continues to generate real-time insights — the PLACENTAL-UK study’s interim analysis (n=2,117), released in April 2024, identified placental T2* relaxation time <35 ms at 34 weeks as predictive of neonatal unit admission with 81% accuracy. This biomarker is now being integrated into UHB’s fetal MRI reporting template — the first NHS trust to do so.
Dr. Sindhu’s story is not one of solitary genius, but of sustained, strategic, and solidarity-driven leadership — rooted in the conviction that every woman deserves care shaped not by her postcode or passport, but by the best available science, delivered with unwavering respect. Her legacy is already visible in lowered stillbirth rates, higher breastfeeding initiation, and trainees who lead with data and compassion — and it is still being written, one carefully measured, deeply human interaction at a time.
